Evidence map›Paper›PMID 34856014›Full record

ArticleAmerican journal of hematology2022

First and fatal case of autoimmune acquired factor XIII/13 deficiency after COVID-19/SARS-CoV-2 vaccination.

Saori Shimoyama, Yuji Kanisawa, Kento Ono, Masayoshi Souri, Akitada Ichinose

Abstract readCase Reports
In one paragraph

Article in American journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Acquired factor XIII deficiency: A scoping review.European journal of anaesthesiology and intensive care · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Coagulation factor inhibitors in COVID-19: From SARS-CoV-2 vaccination to infection.Research and practice in thrombosis and haemostasis · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saori ShimoyamaDepartment of Hematology, Oji General Hospital, Tomakomai, Japan.
Yuji KanisawaDepartment of Hematology, Oji General Hospital, Tomakomai, Japan.
Kento OnoDepartment of Hematology, Oji General Hospital, Tomakomai, Japan.
Masayoshi SouriDepartment of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, Japan.
Akitada IchinoseDepartment of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, Japan.ORCID 0000-0002-3807-5628

Funding

Japanese Ministry of Health, Labor, and Welfare 21FC1008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAutoimmune DiseasesBNT162 VaccineCOVID-19Factor XIII DeficiencyFemaleHumansSARS-CoV-2VaccinationBNT162 Vaccine

Identifiers

PMID34856014
PMCPMC9011653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.